AI-POWERED TREATMENT INTELLIGENCE · NEXT 100 YEARS

The Future of
Drug Utilization
is Here

DUYA is a world-class precision medicine platform that optimizes treatment protocols across all disease categories — powered by AI, biomarker intelligence, and a growing global dataset.

0
DRUGS TRACKED
0
DISEASE CATEGORIES
0
PATIENT RECORDS
0
% TREATMENT SUCCESS
🩸 DIABETES · Type 1 & 2 ❤️ HYPERTENSION · Stage I & II 🫁 RESPIRATORY · Asthma · COPD 💓 CARDIAC · IHD · Heart Failure 🦠 INFECTIONS · Bacterial · Fungal · Viral 🫀 LIVER DISEASE · NAFLD · Hepatitis 🫘 RENAL DISEASE · CKD · Nephrotic 🧠 NEUROLOGICAL · Epilepsy · Migraine 🔬 ONCOLOGY · Supportive Care 🦋 THYROID · Hypo & Hyperthyroidism 🫃 GI TRACT · GERD · IBD · PUD 🫧 DERMATOLOGY · Psoriasis · Eczema 🩸 DIABETES · Type 1 & 2 ❤️ HYPERTENSION · Stage I & II 🫁 RESPIRATORY · Asthma · COPD 💓 CARDIAC · IHD · Heart Failure 🦠 INFECTIONS · Bacterial · Fungal · Viral 🫀 LIVER DISEASE · NAFLD · Hepatitis 🫘 RENAL DISEASE · CKD · Nephrotic 🧠 NEUROLOGICAL · Epilepsy · Migraine 🔬 ONCOLOGY · Supportive Care 🦋 THYROID · Hypo & Hyperthyroidism 🫃 GI TRACT · GERD · IBD · PUD 🫧 DERMATOLOGY · Psoriasis · Eczema

Precision medicine
for every human
on Earth

DUYA collects, processes, and learns from real-world treatment data to generate hyper-personalized drug recommendations — factoring in genetics, biomarkers, comorbidities, regional patterns, and drug availability.

🧬

Genomic-Aware Dosing

Factor in pharmacogenomics — CYP enzyme variants that alter how drugs are metabolized in individual patients.

🌍

Regional Intelligence

Local resistance patterns, drug availability, pricing, and formulary data to guide real-world prescribing.

Real-Time Adaptation

Treatment plans that evolve with the patient — updating recommendations as labs, symptoms, and adherence data flow in.

DUYA LIVE ANALYSIS — SAMPLE
82%
RESPONSE SCORE
91%
ADHERENCE
18%
SE RISK
Day 47
TREATMENT DAY
Metformin 1000mg BD85%
Empagliflozin 10mg79%
Linagliptin 5mg68%
💡 DUYA Insight: Move Metformin to evening dose with dinner — projected +22% absorption improvement based on 2,847 similar profiles.

Every disease.
One platform.

🩸
Diabetes
ICD E11
52 active protocols
❤️
Hypertension
ICD I10
47 active protocols
🦠
Infections
ICD B99
38 active protocols
🫁
Respiratory
ICD J45
31 active protocols
💓
Cardiac
ICD I25
24 active protocols
🫀
Liver Disease
ICD K76
19 active protocols
🫘
Renal Disease
ICD N18
16 active protocols
🧠
Neurological
ICD G40
14 active protocols
🔬
Oncology
ICD C00
11 active protocols
🦋
Thyroid
ICD E05
18 active protocols
🫃
GI Tract
ICD K92
22 active protocols
🫧
Dermatology
ICD L00
15 active protocols

Built on the world's
richest clinical dataset

Every treatment, every outcome, every biomarker — continuously collected, anonymized, and fed into DUYA's adaptive AI to sharpen every future recommendation.

0
Million Data Points Collected
Real-world treatment outcomes, lab results, adverse events, and adherence patterns from partner clinics and hospitals across South Asia.
REAL WORLD EVIDENCE
0
Drug Profiles Maintained
Comprehensive drug profiles including pharmacokinetics, interactions, optimal timing windows, regional availability, and generic alternatives.
DRUG INTELLIGENCE
0
% Interaction Accuracy
Our drug–drug and drug–food interaction engine is trained on 40+ years of pharmacovigilance data, flagging risks before they reach the patient.
SAFETY ENGINE

Intelligence at
every clinical touchpoint

01 · DRUG OPTIMIZATION

The right drug,
the right dose,
the right time

DUYA's AI analyzes 200+ patient variables to rank treatment options by predicted efficacy and safety — not just guidelines, but what works for this specific patient.

  • Efficacy scoring based on matched population outcomes
  • Side effect risk stratification per patient profile
  • Chronotherapy — optimal dosing timing per drug class
  • Generic substitution with bioequivalence confidence scores
DUYA TREATMENT RANKER
Amlodipine 5mg — PM
88%
Losartan 50mg
82%
Lisinopril 10mg
76%
HCTZ 12.5mg
61%
⏱ Smart Timing: Amlodipine PM reduces SBP by 8 mmHg vs AM dosing
BIOMARKER DASHBOARD
HbA1c
8.1 %
CRITICAL
ALT (SGPT)
52 U/L
WARNING
eGFR
61 mL/min
MONITOR
WBC
7.8 ×10³
NORMAL
CRP
6.2 mg/L
ELEVATED
Creatinine
1.1 mg/dL
NORMAL
02 · BIOMARKER ENGINE

Labs that
speak directly
to treatment

DUYA's minimal biomarker engine identifies the highest-signal lab values per disease — and maps them directly to dosing decisions, monitoring schedules, and safety flags.

  • LFT, KFT, CBC, HbA1c, CRP, TSH — all integrated
  • Automatic dose adjustments based on renal/hepatic function
  • Alerts triggered before values reach dangerous thresholds
  • Longitudinal tracking with trend analysis
03 · TREATMENT TIMELINE

Every patient
on a personalized
journey

DUYA maps the entire treatment arc — from initiation to monitoring checkpoints, dose adjustments, and outcome measurement — automatically adapting based on real data.

  • Milestone-based treatment tracking (Day 0 → Day 90 → Annual)
  • Adaptive protocol updates from incoming lab values
  • Adherence monitoring and smart reminders
  • Outcome documentation for population learning
PATIENT TIMELINE — 90 DAYS
Treatment Initiated
Metformin 500mg BD + baseline labs drawn
Day 0
Dose Escalation
HbA1c 8.1% → Metformin ↑ to 1000mg BD
Day 14
Lab Alert — ALT ↑
52 U/L detected · Monitoring intensified
Day 30
Combination Added
Empagliflozin 10mg · HbA1c now 7.2% ✅
Day 90
Annual review · Eye & foot exam scheduled
Day 365
2125

Designed for the
next 100 years
of medicine

DUYA is not a product. It is infrastructure. We are building the data architecture, AI models, and clinical workflows that will power personalized medicine for every human alive — today and a century from now.

🧬
Genomic Integration
As pharmacogenomics matures, DUYA will incorporate genetic profiles to eliminate trial-and-error prescribing entirely.
🌐
Global Disease Atlas
A continuously updated map of drug efficacy, resistance, and outcomes — by region, population, and time — informing health policy worldwide.
🤖
Autonomous Monitoring
AI agents that watch patient data streams 24/7, intervening before adverse events occur and adjusting plans without clinician bottlenecks.
💊
Drug Discovery Feedback
Real-world DUYA data feeds back into pharmaceutical R&D — revealing which drugs underperform, which populations are underserved, and where gaps exist.
🏥
Universal Accessibility
From tertiary hospitals to rural dispensaries — DUYA's recommendations adapt to resource constraints and local drug availability at every level.
📡
Federated Learning
Privacy-preserving AI training across thousands of institutions globally — sharing intelligence without sharing patient data.

Contribute. Advance.
Transform medicine.

Every data point submitted to DUYA improves treatment outcomes for future patients. Clinicians, researchers, and institutions — join the world's most ambitious medical dataset.

PATIENT CASE DATA SUBMISSION
PATIENT PARAMETERS (ANONYMIZED)
DATA SHARING CONSENT
🔒 All submitted data is encrypted, anonymized, and stored in compliance with international healthcare data standards (HIPAA, GDPR). No personally identifiable patient information should be submitted. Read our Privacy Policy →
Data Submitted Successfully
Thank you for contributing to DUYA's global dataset. Your case data has been encrypted and queued for validation. The DUYA team will be in touch.
0
Patient Records in DUYA
Across 43 partner clinics, 18 districts, and 12 disease categories — and growing every day.
Diabetes Hypertension Infections Cardiac Respiratory + 7 more
0
Drug Profiles in Database
Every drug in DUYA carries efficacy scores, safety profiles, interaction flags, optimal timing data, and regional availability.
0
Partner Institutions
Clinics, hospitals, and research centers contributing de-identified real-world data to DUYA's growing intelligence network.
WHY CONTRIBUTE?
Every case you submit trains models that improve your future patients' outcomes
Get access to DUYA's regional drug efficacy and resistance reports
Be listed as a DUYA contributing researcher in publications
Earn early access to the DUYA clinical decision support platform

Join the DUYA Network

Whether you're a clinician, researcher, pharmacist, hospital administrator, or health tech innovator — DUYA has a place for you in building the future of medicine.

BUILT FOR — TRUSTED BY

Clinicians who
trust DUYA

"
DUYA flagged a warfarin–NSAID interaction for one of my patients before I prescribed. The system is already thinking ahead of me in ways I didn't expect from a platform this early in its development.
👨‍⚕️
Dr. Tariq Mahmud
Cardiologist, Dhaka
"
The chronotherapy insight alone changed how I prescribe amlodipine. Moving my hypertensive patients to evening dosing has measurably improved their 24-hour BP profiles. Evidence-based, real results.
👩‍⚕️
Dr. Nusrat Jahan
Internal Medicine, Chittagong
"
As a researcher, the ability to access de-identified treatment outcome data across thousands of patients is transformative. DUYA is building the dataset that Bangladesh's pharmacology community has needed for decades.
🧑‍🔬
Prof. A.K.M. Sayeed
Clinical Pharmacology, BSMMU

The next century
of medicine
starts here

Join 247 clinicians, 43 institutions, and 12 researchers already shaping DUYA's global health intelligence platform.

No spam. Research insights only. Unsubscribe anytime.

Scroll to Top